PTX 2.44% 4.2¢ prescient therapeutics limited

I think this statement doesn't help with the SP movement:...

  1. 428 Posts.
    lightbulb Created with Sketch. 69
    I think this statement doesn't help with the SP movement: "...which may commensurately extend the study period." How long will this extend the study for? Shareholder patience is tested in biotech stocks which curbs enthusiasm IMO.

    Good to see the drug is safe and has some degree of efficacy.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.